US Bills targeting Hizballah

The US House of Representatives has passed two Bills and agreed to a Simple Resolution targeting Hizballah.

The Hizballah International Financing Prevention Amendments Act of 2017 requires the President to impose sanctions on any foreign person that “knowingly assists, sponsors, or, provides significant financial, material, or technological support for” Hizballah.

The Sanctioning Hizballah’s Illicit Use of Civilians as Defenseless Shields Act, requires the President to identify and impose sanctions on any foreign person affiliated with Hizballah, who is “responsible for or complicit in, or responsible for ordering, controlling, or otherwise directing, the use of civilians as human shields”, as well as those who “[attempt] to provide, or significantly [facilitate] the provision of, material support” to such a person. Both Bills now go to the US Senate to vote on them.

The Simple Resolution (which doesn’t require Congressional approval), Urging the European Union to designate Hizballah in its entirety as a terrorist organization and increase pressure on it and its members, encourages the EU to “implement sanctions against Hizballah-affiliated terrorists in tandem with the United States”, and “urges the EU to designate Hizballah in its entirety as a terrorist organization and increase pressure on the group” through a number of proposals. The EU currently designates only Hizballah’s military wing (see previous blog here).

The House of Representatives is also due to vote on the Iran Ballistic Missiles and International Sanctions Enforcement Act, which expand sanctions on Iran with respect to ballistic missiles.

TerrorismTerrorism IranIran United StatesUnited States

About Michael O'Kane

Michael O'Kane

Michael was called to the Bar in 1992 and prior to joining Peters & Peters was a senior specialist prosecutor at the Crown Prosecution Service Headquarters (CPS). He was a key member of a small specialist unit responsible for the prosecution of serious and high-profile fraud, terrorist,...

See profile for Michael O'Kane >